{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:32:26Z","timestamp":1777480346695,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2021,9,24]]},"abstract":"<jats:p>BACKGROUND: Neuronatin (NNAT) determined by immunohistochemistry is a negative prognostic biomarker for breast cancer, independent of the major clinicopathological markers. OBJECTIVE: Here, we investigated whether NNAT is also a predictive biomarker for pathological remission after neoadjuvant chemotherapy. METHODS : One hundred and four breast cancer patients, treated with systemic neoadjuvant chemotherapy were included in this retrospective study. NNAT was detected in formaldehyde fixed, paraffin embedded primary cancer tissue by immunohistochemistry and an immuno-reactive score (IRS) determined. Pathological remission was scored according to Sinn and by evaluation of cytopathic effects. NNAT-IRS was correlated with clinicopathological parameters as well as relapse free and overall survival and for pathological remission after neoadjuvant therapy. RESULTS: NNAT IRS was an independent prognostic marker for relapse free and overall survival and the time from diagnosis to the \u201ctumor-free\u201d state. NNAT IRS was associated with Luminal-A tumors and correlated slightly negative with age and lymph-node metastasis. There was no significant correlation of NNAT-IRS with Sinn\u2019s remission score, but with cytopathic effects of chemotherapy. CONCLUSIONS: We confirmed the prognostic impact of NNAT-IRS in an independent cohort of neoadjuvantly treated patients. Additionally, a correlation with a score for pathological remission under systemic neoadjuvant chemotherapy for breast cancer was found.<\/jats:p>","DOI":"10.3233\/cbm-203127","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T12:34:12Z","timestamp":1622810052000},"page":"161-173","source":"Crossref","is-referenced-by-count":5,"title":["The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer"],"prefix":"10.1177","volume":"32","author":[{"given":"Willi","family":"Pieper","sequence":"first","affiliation":[{"name":"Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atanas","family":"Ignatov","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Otto von Guericke University, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kalinski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany"},{"name":"Department of Pathology, Neuropathology, and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"Department of Pathology, Diagnostic and Research Center for Molecular BioMedicine, Institute of Pathology, Medical University of Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Czapiewski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany"},{"name":"Department of Pathology, Dessau Medical Center, Dessau, Germany"},{"name":"Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Nass","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany"},{"name":"Department for Internal Medicine I, Dessau Medical Center, Dessau, Germany"},{"name":"Department of Pathology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-203127_ref1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.3233\/CBM-203127_ref2","first-page":"401M","article-title":"Precision medicine in breast cancer","volume":"88","author":"Odle","year":"2017","journal-title":"Radiol Technol"},{"key":"10.3233\/CBM-203127_ref3","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"10.3233\/CBM-203127_ref4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.3233\/CBM-203127_ref5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for premenopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-203127_ref6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(11)61128-8","article-title":"With maturity comes confidence: EBCTCG tamoxifen update","volume":"378","author":"Chia","year":"2011","journal-title":"The Lancet"},{"key":"10.3233\/CBM-203127_ref7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejmech.2015.08.010","article-title":"Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer","volume":"102","author":"Ahmad","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.3233\/CBM-203127_ref8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40259-016-0162-9","article-title":"Trastuzumab in the treatment of breast cancer","volume":"30","author":"Maximiano","year":"2016","journal-title":"BioDrugs"},{"key":"10.3233\/CBM-203127_ref9","unstructured":"C. Anders and L.A. Carey, Understanding and treating triple-negative breast cancer, Oncology (Williston Park, NY) 22 (2008), 1233\u20131239; discussion 1239\u20131240, 1243."},{"key":"10.3233\/CBM-203127_ref10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.14423\/SMJ.0000000000000703","article-title":"Neoadjuvant and adjuvant therapies for breast cancer","volume":"110","author":"Apuri","year":"2017","journal-title":"South Med J"},{"key":"10.3233\/CBM-203127_ref11","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials, Lancet Oncol 19 (2018), 27\u201339."},{"key":"10.3233\/CBM-203127_ref12","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.2003.01.136","article-title":"International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations","volume":"21","author":"Kaufmann","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-203127_ref13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-010-1228-x","article-title":"Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials","volume":"125","author":"von Minckwitz","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/CBM-203127_ref14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1055\/s-2007-1022338","article-title":"Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy","volume":"54","author":"Sinn","year":"1994","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.3233\/CBM-203127_ref15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4048\/jbc.2019.22.e49","article-title":"Predictive and prognostic roles of pathological indicators for patients with breast cancer on neoadjuvant chemotherapy","volume":"22","author":"Li","year":"2019","journal-title":"J Breast Cancer"},{"issue":"1","key":"10.3233\/CBM-203127_ref16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00428-017-2154-7","article-title":"High neuronatin (NNAT) expression is associated with poor outcome in breast cancer","volume":"471","author":"Nass","year":"2017","journal-title":"Virchows Archiv"},{"key":"10.3233\/CBM-203127_ref17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0006-8993(95)00621-V","article-title":"Neuronatin mRNA: alternatively spliced forms of a novel brain-specific mammalian developmental gene","volume":"690","author":"Joseph","year":"1995","journal-title":"Brain Res"},{"key":"10.3233\/CBM-203127_ref18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygeno.2013.12.001","article-title":"Neuronatin gene: Imprinted and misfolded: studies in lafora disease, diabetes and cancer may implicate NNAT-aggregates as a common downstream participant in neuronal loss","volume":"103","author":"Joseph","year":"2014","journal-title":"Genomics"},{"key":"10.3233\/CBM-203127_ref19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2011.06.013","article-title":"Lafora disease ubiquitin ligase malin promotes proteasomal degradation of neuronatin and regulates glycogen synthesis","volume":"44","author":"Sharma","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.3233\/CBM-203127_ref20","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.2337\/db07-1746","article-title":"Neuronatin: a new inflammation gene expressed on the aortic endothelium of diabetic mice","volume":"57","author":"Mzhavia","year":"2008","journal-title":"Diabetes"},{"key":"10.3233\/CBM-203127_ref21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1677\/ERC-09-0008","article-title":"Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma","volume":"16","author":"Revill","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.3233\/CBM-203127_ref22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/JTO.0b013e318145af5e","article-title":"Neuronatin expression and its clinicopathological significance in pulmonary non-small cell carcinoma","volume":"2","author":"Uchihara","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.3233\/CBM-203127_ref23","doi-asserted-by":"crossref","first-page":"e37811","DOI":"10.1371\/journal.pone.0037811","article-title":"Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.3233\/CBM-203127_ref24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1215\/15228517-2008-038","article-title":"Coexpression of neuronatin splice forms promotes medulloblastoma growth","volume":"10","author":"Siu","year":"2008","journal-title":"Neuro-oncology"},{"key":"10.3233\/CBM-203127_ref25","doi-asserted-by":"crossref","first-page":"r137","DOI":"10.1186\/gb-2013-14-12-r137","article-title":"Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas","volume":"14","author":"Renner","year":"2013","journal-title":"Genome Biol"},{"key":"10.3233\/CBM-203127_ref26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/geno.2001.6612","article-title":"The neuronatin gene resides in a \u201cmicro-imprinted\u201d domain on human chromosome 20q11.2","volume":"77","author":"Evans","year":"2001","journal-title":"Genomics"},{"key":"10.3233\/CBM-203127_ref27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccr.2012.11.019","article-title":"Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration","volume":"23","author":"Ryu","year":"2013","journal-title":"Cancer Cell"},{"key":"10.3233\/CBM-203127_ref28","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1038\/oncsis.2015.18","article-title":"Metformin induces ER stress-dependent apoptosis through miR-708-5p\/NNAT pathway in prostate cancer","volume":"4","author":"Yang","year":"2015","journal-title":"Oncogenesis"},{"key":"10.3233\/CBM-203127_ref29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10549-019-05307-8","article-title":"Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome","volume":"177","author":"Plasterer","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/CBM-203127_ref30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1535-7163.151.4.1","article-title":"Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366\/TAM","volume":"4","author":"Becker","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.3233\/CBM-203127_ref32","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.3233\/CBM-203127_ref33","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/CBM-203127_ref34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.3233\/CBM-203127_ref35","doi-asserted-by":"publisher","DOI":"10.3390\/biom9090503"},{"key":"10.3233\/CBM-203127_ref36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clbc.2016.10.003","article-title":"Impact of interaction between PPAR alpha and PPAR gamma on breast cancer risk in the chinese han population","volume":"17","author":"Lianggeng","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.3233\/CBM-203127_ref37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.6026\/97320630015799","article-title":"Towards the early detection of ductal carcinoma (a common type of breast cancer) using biomarkers linked to the PPAR(\u03b3) signaling pathway","volume":"15","author":"Sultan","year":"2019","journal-title":"Bioinformation"},{"key":"10.3233\/CBM-203127_ref38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.lfs.2016.10.014","article-title":"Disruption of calcium homeostasis by cardiac-specific over-expression of PPAR-\u03b3 in mice: a role in ventricular arrhythmia","volume":"167","author":"Xie","year":"2016","journal-title":"Life Sci"},{"key":"10.3233\/CBM-203127_ref39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Gy\u00f6rffy","year":"2010","journal-title":"Breast Cancer Research and Treatment"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-203127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:16Z","timestamp":1777385296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-203127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":38,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-203127","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}